UK stocks clawed back some of their earlier losses on Monday as a mix of political tensions in Hong Kong and weaker than expected growth...

Paul Hogarth, Chief Executive Officer, bought 90,726 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds...

Paul Edwards, Financial Director, bought 45,364 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds 94,864...

Lothan Mentel, Executive Director, bought 25,797 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds 991,785...

Chris Poil, Non Executive Director, bought 45,000 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds...

Bill Floydd, Executive Director, bought 25,000 shares in the company on the 11th November 2019 at a price of 215.75p. The Director now holds 25,000...

Helen Bunch, Non Executive Director, bought 1,103 shares in the company on the 11th November 2019 at a price of 269.14p. The Director now holds...

Simon Hayes, Non Executive Director, has re-invested 328 shares in the company on the 8th November 2019 at a price of 888.20p. The Director now...

Caner and neurological-condition focused Evgen Pharma said a trial of a treatment for subarachnoid haemorrhage, a type of stroke, had failed to achieve its primary...